Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis

NARecruitingINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

May 19, 2021

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
ThrombocytopeniaImmune ThrombocytopeniaMyelodysplasia
Interventions
BIOLOGICAL

Blood samples

"* Thrombopoietin : 7 ml whole blood.~* Anti-platelet antibodies free : 14 ml whole blood.~* Anti-platelet antibodies bound :~If the platelet count is ≥ 50 G / L : 14 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation ; If the platelet count is \< 50 G / L and ≥ 20 G / L : 28 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation ; If the platelet count is \< 20 G / L and ≥ 10 G / L: 42 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation ; If the platelet count is \< 10 G / L : 49 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation."

Trial Locations (1)

Unknown

RECRUITING

CHU de Bordeaux - service de médecine interne, Pessac

All Listed Sponsors
collaborator

Ministry for Health and Solidarity, France

OTHER_GOV

lead

University Hospital, Bordeaux

OTHER